E Fund Management Co., Ltd. Biocryst Pharmaceuticals Inc Transaction History

E Fund Management Co., Ltd.

$2.07 Billion
Q1 2025

A detailed history of E Fund Management Co., Ltd. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 23,674 shares of BCRX stock, worth $194,600. This represents 0.01% of its overall portfolio holdings.

Number of Shares

23,674

Previous 16,612 42.51%

Holding current value

$194,600

Previous $124,000 42.74%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$7.06 - $9.39 $49,857 - $66,312	7,062 Added 42.51%	23,674 $177,000
Q4 2024 Feb 06, 2025	SELL	$7.03 - $8.43 $50,798 - $60,915	-7,226 Reduced 30.31%	16,612 $124,000
Q3 2024 Nov 12, 2024	SELL	$6.41 - $8.69 $28,505 - $38,644	-4,447 Reduced 15.72%	23,838 $181,000
Q2 2024 Aug 12, 2024	SELL	$4.13 - $6.79 $189,546 - $311,627	-45,895 Reduced 61.87%	28,285 $174,000
Q1 2024 May 13, 2024	BUY	$4.89 - $7.65 $111,800 - $174,901	22,863 Added 44.55%	74,180 $376,000
Q4 2023 Feb 06, 2024	BUY	$4.98 - $6.77 $48,903 - $66,481	9,820 Added 23.66%	51,317 $307,000
Q3 2023 Nov 13, 2023	SELL	$6.71 - $7.92 $73,313 - $86,533	-10,926 Reduced 20.84%	41,497 $294,000
Q2 2023 Aug 11, 2023	BUY	$6.96 - $8.81 $40,632 - $51,432	5,838 Added 12.53%	52,423 $369,000
Q1 2023 May 11, 2023	BUY	$7.94 - $11.84 $50,260 - $74,947	6,330 Added 15.72%	46,585 $389,000
Q4 2022 Feb 14, 2023	BUY	$10.5 - $14.2 $50,799 - $68,699	4,838 Added 13.66%	40,255 $462,000
Q3 2022 Nov 14, 2022	SELL	$10.79 - $14.81 $97,012 - $133,156	-8,991 Reduced 20.25%	35,417 $446,000
Q2 2022 Aug 15, 2022	BUY	$7.89 - $17.88 $219,081 - $496,473	27,767 Added 166.86%	44,408 $470,000
Q1 2022 May 12, 2022	BUY	$11.56 - $19.76 $20,299 - $34,698	1,756 Added 11.8%	16,641 $271,000
Q4 2021 Feb 11, 2022	BUY	$11.18 - $15.46 $39,532 - $54,666	3,536 Added 31.16%	14,885 $206,000
Q3 2021 Nov 12, 2021	BUY	$14.21 - $17.65 $5,385 - $6,689	379 Added 3.45%	11,349 $163,000
Q1 2021 May 12, 2021	BUY	$7.37 - $13.61 $80,848 - $149,301	10,970 New	10,970 $111,000

Others Institutions Holding BCRX

# of Institutions

295

Shares Held

181M

Call Options Held

721K

Put Options Held

489K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.53B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.

Account

E Fund Management Co., Ltd. Biocryst Pharmaceuticals Inc Transaction History